Company Filing History:
Years Active: 2015
Title: Francesca Porta: Innovator in Pharmaceutical Chemistry
Introduction
Francesca Porta is a notable inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on crystalline forms of specific compounds. Her research has implications for drug development and therapeutic applications.
Latest Patents
Francesca Porta holds a patent for "Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline." This invention relates to the solid state of the compound and introduces novel crystalline forms of the base, as well as pharmaceutically acceptable salts and solvates. The patent also details methods for preparing these forms, their respective pharmaceutical formulations, and their therapeutic uses. Compound (I) can be obtained as the free base in five different crystalline forms, including three polymorphic forms and two hydrates. Some pharmaceutically acceptable salts of this compound have been characterized with physicochemical properties suitable for pharmaceutical development.
Career Highlights
Francesca Porta is currently associated with Rottapharm Spa, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of crystalline forms in pharmaceutical applications.
Collaborations
Francesca has collaborated with notable colleagues, including Antonio Giordani and Stefano Mandelli, contributing to a dynamic research environment that fosters innovation.
Conclusion
Francesca Porta's contributions to pharmaceutical chemistry, particularly through her patent on crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline, highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also has practical implications for drug development.